For three weeks, beginning May 4 and ending May 24, the Department of Health and Human Services said it delivered to states, territories and government agencies more than 12,000 cases of 40 vials each of remdesivir to help treat COVID-19 infections.

Every state and territory has received at least one shipment, and hospitals are asked to continue inputting data for future allocations. The administration said 80% of the allocated drugs was based on the number of confirmed or suspected COVID-19 cases reported in the TeleTracking platform. Less than 10% of Gilead Sciences Inc.’s original 600,000 vial donation is being held for emerging hotspots, and Gilead said it plans to donate an additional 330,000 vials by the end of June.

Headline
The Department of Health of Human Services Aug. 21 issued a request for information seeking feedback on immunization categories within the Aug. 10 executive…
Headline
For the 2025-2026 school year, exemptions from one or more vaccines among U.S. kindergartners was at 4.2%, increasing from 3.6% for the previous school year,…
Headline
A study published Aug. 5 by Nature found that COVID-19 infection can reactivate dormant, chronic viruses such as Epstein-Barr and cytomegalovirus. The study…
Headline
The Department of Health and Human Services June 30 announced it will terminate emergency use authorization declarations for certain drugs and medical devices…
Headline
Centers for Medicare & Medicaid Services Administrator Mehmet Oz, M.D., and CMS Deputy Administrator and Director of Medicaid and CHIP Dan Brillman sat…
Headline
Flu and COVID-19 vaccination rates among all health care workers for the 2024-25 respiratory virus season was 76.3% and 40.2%, respectively, according to a…